- Home
- CRDF vs PHT Comparison
CRDF vs PHT Comparison
Compare CRDF & PHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- PHT
- Stock Information
- Founded
- CRDF 1999
- PHT 2002
- Country
- CRDF United States
- PHT United States
- Employees
- CRDF N/A
- PHT N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- PHT Investment Managers
- Sector
- CRDF Health Care
- PHT Finance
- Exchange
- CRDF Nasdaq
- PHT Nasdaq
- Market Cap
- CRDF 288.7M
- PHT 231.2M
- IPO Year
- CRDF N/A
- PHT N/A
- Fundamental
- Price
- CRDF $3.19
- PHT $7.73
- Analyst Decision
- CRDF Strong Buy
- PHT
- Analyst Count
- CRDF 4
- PHT 0
- Target Price
- CRDF $12.00
- PHT N/A
- AVG Volume (30 Days)
- CRDF 1.1M
- PHT 85.5K
- Earning Date
- CRDF 05-01-2025
- PHT 01-01-0001
- Dividend Yield
- CRDF N/A
- PHT 8.76%
- EPS Growth
- CRDF N/A
- PHT N/A
- EPS
- CRDF N/A
- PHT 0.98
- Revenue
- CRDF $683,000.00
- PHT N/A
- Revenue This Year
- CRDF N/A
- PHT N/A
- Revenue Next Year
- CRDF N/A
- PHT N/A
- P/E Ratio
- CRDF N/A
- PHT $7.71
- Revenue Growth
- CRDF 39.96
- PHT N/A
- 52 Week Low
- CRDF $2.01
- PHT $6.41
- 52 Week High
- CRDF $6.38
- PHT $7.60
- Technical
- Relative Strength Index (RSI)
- CRDF 34.89
- PHT 47.74
- Support Level
- CRDF $3.65
- PHT $7.69
- Resistance Level
- CRDF $3.88
- PHT $7.76
- Average True Range (ATR)
- CRDF 0.25
- PHT 0.06
- MACD
- CRDF -0.07
- PHT 0.01
- Stochastic Oscillator
- CRDF 8.21
- PHT 82.61
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About PHT Pioneer High Income Fund Inc.
Pioneer High Income Trust is a closed-end management investment company. Its investment objective is to provide a high level of current income and to seek capital appreciation by investing predominantly in below investment grade (high-yield) debt securities, loans, and preferred stocks.